
Survival studies in paediatric oncology in Romania
Our experts carried out two survival studies, in 2019 and 2024, based on data from the National Paediatric Onco-Haematology Registry. Both have been validated by experts from the European Network of Cancer Registries.
Completed
15.02.2024 – Palatul Parlamentului – Presentation of the second survival study
Survival studies in paediatric cancer are carried out worldwide on the basis of cancer registries.
Registrul Național de Onco-Hematologie Pediatrică in our country is a joint project of Asociația Dăruiește Aripi and Societatea Română de Onco-Hematologie Pediatrică.
We can say that we have a complete and valid survival analysis of children with cancer in Romania, an essential step in aligning our country with international standards.
2019 survival study
Five-year survival from the date of diagnosis for cases diagnosed between 2010 – 2013 was 69.4% for the 0-14 age group, in line with the average for Eastern European countries, but 10% lower than the average for Western European countries.
2024 survival study
Five-year survival, from the date of diagnosis for cases diagnosed between 2014 – 2017 is 74% for the 0-14 age group, the European Union average being 81%, and the Eastern Europe average 71% (according to EUROCARE 6).